Reena Mehra1,2,3, Lu Wang4, Noah Andrews1, W H Wilson Tang1,2,3, James B Young2, Shahrokh Javaheri5, Nancy Foldvary-Schaefer1. 1. Sleep Disorders Center, Neurologic Institute, Cleveland Clinic, Cleveland, Ohio. 2. Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio. 3. Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio. 4. Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio. 5. Sleep Laboratory, Bethesda North Hospital, Cincinnati, Ohio.
Abstract
STUDY OBJECTIVES: Subjective versus objective sleepiness in heart failure (HF) remains understudied; therefore, we sought to examine the association of these measures and interrelationships with biochemical markers. METHODS: Participants with stable systolic HF recruited from a clinic-based program underwent attended polysomnography, Multiple Sleep Latency Testing, questionnaire data collection including Epworth Sleepiness Scale (ESS), and morning phlebotomy for biochemical markers. Linear regression was used to assess the association of mean sleep latency (MSL) and ESS (and other reported outcomes) with adjustment of age or body mass index or left ventricular ejection fraction (LVEF) (beta coefficients, 95% confidence interval) and also with biochemical markers (beta coefficients, 95% confidence interval). RESULTS: The final analytic sample comprised 26 participants: 52 ± 14 years with apnea-hypopnea index (AHI): 34 ± 27, LVEF: 34 ± 12%, MSL: 7 ± 5 minutes and ESS: 7 (5, 10). There was no significant association of MSL and ESS (-0.36, -0.81 to 0.09, P = .11), AHI, or other questionnaire-based outcomes in adjusted analyses. Although statistically significant associations of ESS and biomarkers were not observed, there were associations of MSL and cortisol (μg/dL) [-0.05: -0.08, -0.01, P = .012] and interleukin-6 (pg/mL) [-0.11: -0.18, -0.04, P = .006], which persisted in adjusted models. CONCLUSIONS: In systolic HF, although overall objective sleepiness was observed, this was not associated with subjective sleepiness (ie, a discordance was identified). Differential upregulation of systemic inflammation in objective sleepiness was observed, findings not observed with subjective sleepiness. These findings suggest that underlying mechanistic pathways of inflammation may provide the explanation for dissonance of objective and subjective sleepiness symptoms in HF, thus potentially informing targeted diagnostic and therapeutic approaches. COMMENTARY: A commentary on this article appears in this issue on page 1369.
STUDY OBJECTIVES: Subjective versus objective sleepiness in heart failure (HF) remains understudied; therefore, we sought to examine the association of these measures and interrelationships with biochemical markers. METHODS:Participants with stable systolic HF recruited from a clinic-based program underwent attended polysomnography, Multiple Sleep Latency Testing, questionnaire data collection including Epworth Sleepiness Scale (ESS), and morning phlebotomy for biochemical markers. Linear regression was used to assess the association of mean sleep latency (MSL) and ESS (and other reported outcomes) with adjustment of age or body mass index or left ventricular ejection fraction (LVEF) (beta coefficients, 95% confidence interval) and also with biochemical markers (beta coefficients, 95% confidence interval). RESULTS: The final analytic sample comprised 26 participants: 52 ± 14 years with apnea-hypopnea index (AHI): 34 ± 27, LVEF: 34 ± 12%, MSL: 7 ± 5 minutes and ESS: 7 (5, 10). There was no significant association of MSL and ESS (-0.36, -0.81 to 0.09, P = .11), AHI, or other questionnaire-based outcomes in adjusted analyses. Although statistically significant associations of ESS and biomarkers were not observed, there were associations of MSL and cortisol (μg/dL) [-0.05: -0.08, -0.01, P = .012] and interleukin-6 (pg/mL) [-0.11: -0.18, -0.04, P = .006], which persisted in adjusted models. CONCLUSIONS: In systolic HF, although overall objective sleepiness was observed, this was not associated with subjective sleepiness (ie, a discordance was identified). Differential upregulation of systemic inflammation in objective sleepiness was observed, findings not observed with subjective sleepiness. These findings suggest that underlying mechanistic pathways of inflammation may provide the explanation for dissonance of objective and subjective sleepiness symptoms in HF, thus potentially informing targeted diagnostic and therapeutic approaches. COMMENTARY: A commentary on this article appears in this issue on page 1369.
Authors: Michael Arzt; Terry Young; Laurel Finn; James B Skatrud; Clodagh M Ryan; Gary E Newton; Susanna Mak; John D Parker; John S Floras; T Douglas Bradley Journal: Arch Intern Med Date: 2006-09-18
Authors: Shahrokh Javaheri; Ferran Barbe; Francisco Campos-Rodriguez; Jerome A Dempsey; Rami Khayat; Sogol Javaheri; Atul Malhotra; Miguel A Martinez-Garcia; Reena Mehra; Allan I Pack; Vsevolod Y Polotsky; Susan Redline; Virend K Somers Journal: J Am Coll Cardiol Date: 2017-02-21 Impact factor: 24.094
Authors: Justin C T Pepperell; Nick A Maskell; David R Jones; Beverley A Langford-Wiley; Nicky Crosthwaite; John R Stradling; Robert J O Davies Journal: Am J Respir Crit Care Med Date: 2003-08-19 Impact factor: 21.405
Authors: Terri E Weaver; Greg Maislin; David F Dinges; Thomas Bloxham; Charles F P George; Harly Greenberg; Gihan Kader; Mark Mahowald; Joel Younger; Allan I Pack Journal: Sleep Date: 2007-06 Impact factor: 5.849
Authors: Katharina Heider; Michael Arzt; Christoph Lerzer; Leonie Kolb; Michael Pfeifer; Lars S Maier; Florian Gfüllner; Maximilian Valentin Malfertheiner Journal: Clin Res Cardiol Date: 2018-01-25 Impact factor: 5.460
Authors: Brienne Miner; Katie L Stone; Jamie M Zeitzer; Ling Han; Margaret Doyle; Terri Blackwell; Thomas M Gill; Nancy S Redeker; Alexandra Hajduk; Henry Klar Yaggi Journal: J Clin Sleep Med Date: 2022-02-01 Impact factor: 4.062
Authors: S Liamsombut; R Kaw; L Wang; J Bena; N Andrews; N Collop; T Stierer; M Gillinov; M Tarler; H Kayyali; I Katzan; N Foldvary-Schaefer Journal: Sleep Med Date: 2021-05-15 Impact factor: 4.842